2015
DOI: 10.1016/j.etap.2014.12.018
|View full text |Cite
|
Sign up to set email alerts
|

Future of nano bisdemethoxy curcumin analog: Guaranteeing safer intravenous delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 16 publications
0
3
0
Order By: Relevance
“…The results clearly showed that RFA had no obvious cytotoxicity to PBMC, and may promote proliferation within a certain concentration range. Hemolysis was regarded as the red blood cell toxicity index, the red blood cell hemolysis test of RFA showed that the percentage of hemolysis was less than 2.5%, which met the recognized requirement that the hemolysis rate should not exceed 5% (Guo et al, 2013;Francis et al, 2015). Therefore, we preliminarily believe that RFA is non-toxic and safe.…”
Section: Discussionmentioning
confidence: 81%
See 1 more Smart Citation
“…The results clearly showed that RFA had no obvious cytotoxicity to PBMC, and may promote proliferation within a certain concentration range. Hemolysis was regarded as the red blood cell toxicity index, the red blood cell hemolysis test of RFA showed that the percentage of hemolysis was less than 2.5%, which met the recognized requirement that the hemolysis rate should not exceed 5% (Guo et al, 2013;Francis et al, 2015). Therefore, we preliminarily believe that RFA is non-toxic and safe.…”
Section: Discussionmentioning
confidence: 81%
“…Completely lysed blood is obtained by adding deionized water to a 2% RBC solution. Deionized water was used as a positive control and PBS was used as a negative control (Guo et al, 2013;Francis et al, 2015). The percentage of hemolysis is calculated by the following formula: Hemolysis (%) =(Sample OD-Negative control OD)/(Positive control OD-Negative control OD)×100%.…”
Section: Hemolytic Assaymentioning
confidence: 99%
“…A more recent approach to improve bioavailability of curcumin has been to use nano formulations of curcumin [23,24,25]. Several different nanocurcumin preparations have been made and tested for in vitro as well as in vivo effects and toxicities [26,27,28]. The nano particle formulations of curcumin have been shown to improve bioavailability and therapeutic potential of curcumin and its analogues and can be considered a medium of choice for delivery of curcuminoids [29,30,31,32,33].…”
Section: Introductionmentioning
confidence: 99%